Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
Agfa Healthcare
Schiller

MR Linac Research Consortium to Develop MRI-Guided Radiotherapy for Cancer Treatment

By Medimaging International staff writers
Posted on 16 Jun 2014
High-powered institutions to join consortium to advance MRI-guided radiptherapy. Elekta (Stockholm, Sweden) and Philips Healthcare (Best, The Netherlands) reported that The Institute of Cancer Research (ICR), London, UK), a world-leading cancer research institution, working with its clinical partner the Royal Marsden NHS [National Health Service] Foundation Trust, will join the Elekta MR Linac Research Consortium, a group with an objective to develop an integrated magnetic resonance imaging (MRI)-guided radiation therapy system. Combining a sophisticated digital linac with an MRI system would greatly enhance real-time visualization of cancer targets during the delivery of therapeutic radiation.

“The addition of The Institute of Cancer Research [ICR] to the consortium further strengthens this growing partnership of clinical centers,” said Niklas Savander, Elekta president and CEO. “The ICR is a prominent cancer research institute and has contributed significantly in this arena for over a century. Its unique partnership with The Royal Marsden and ‘bench-to-bedside’ approach allows the ICR to deliver exceptional results. All of these factors make the ICR and The Royal Marsden a perfect fit as we advance MRI-guided radiotherapy.”

“The development of MRI-guided radiation therapy establishes a new vision for clinical radiation oncology for the treatment of cancer,” said Prof. Uwe Oelfke, MCCPM, FInstP, and head of the joint department of physics at The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust. “The translation of this novel technical approach into clinical practice faces a number of challenges ideally addressed by a group of world leading radiotherapy centers, each contributing with its specific expertise. Being a member of the consortium is a prerequisite to shape this exciting future of radiation therapy. Our current Cancer Research UK-funded research program on adaptive and image-guided therapy, together with the activities on MRI within our Cancer Research UK imaging center, are an excellent research environment to make leading contributions to the joint efforts of the consortium. The ICR's initial research focus for MRI-guided radiation therapy will be on pelvic malignancies, where the excellent soft tissue contrast of MR images directly before or during treatment will substantially enhance treatment options and quality.”

The ICR is the sixth member to join the research consortium that assesses the novel technology, which brings together state-of-the-art radiation therapy and MRI in a single system. The consortium also includes the University Medical Center Utrecht (Utrecht, the Netherlands), The University of Texas MD Anderson Cancer Center (Houston, TX, USA), The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (Amsterdam, the Netherlands), Sunnybrook Health Sciences Center (Toronto, Ontario, Canada) and The Froedtert & Medical College of Wisconsin Cancer Center (Milwaukee, WI, USA).

“MRI-guided radiation therapy has the promise to become a highly targeted treatment for cancer,” said Gene Saragnese, CEO imaging systems at Philips Healthcare. “The realization of this promise requires the collaboration between leaders in interventional imaging and radiation therapy delivery, as well as clinical innovators in oncology. We are convinced that the deep clinical knowledge and expertise of the Institute of Cancer Research will be a strong asset to the growing research consortium.”

The research consortium, since its launch in 2012, has taken several steps toward its goal. On April 5, 2014, the University Medical Center Utrecht began installing the first generation MRI-guided radiation therapy system for nonclinical testing, which includes the performance evaluation of MRI pulse sequences, evaluation of different adaptive delivery approaches, establishing quality assurance techniques and defining workflow. Several of the sites are now undertaking treatment planning evaluation using the Monte Carlo based MRI-corrected algorithms in a research version of Elekta’s Monaco treatment planning system. Furthermore, a number of the consortium centers have active research programs linked to the MRI-guided radiation therapy system and have submitted abstracts to the American Association of Physicists in Medicine (AAPM) annual meeting (July 20–24, 2014, Austin, TX, USA), where some specific sessions will be covering the latest advances in MRI-guided radiotherapy.

Related Links:

Elekta 
Philips Healthcare 
Institute of Cancer Research, London



Channels

Radiography

view channel
Image: Agfa HealthCare’s DX-D Mobile Retrofit solution will allow hospitals an easy and affordable way to upgrade existing GE Healthcare’s AMX 4 and 4 plus mobile X-ray systems to direct radiography (DR) (Photo courtesy of Agfa Healthcare).

Retrofit Enables Cost-Effective Upgrade of Existing Mobile X-Ray Systems to Direct Radiography

A mobile retrofit system has been designed to be mounted on mobile X-ray systems to create an easy way for hospitals to go digital without having to replace existing mobile X-ray units. A direct radiography... Read more

Ultrasound

view channel
Image: Ultrasound image of the Circle of Willis (Photo courtesy of the Swedish Cerebrovascular Center, Seattle, WA, USA).

New Approaches for Transcanial Ultrasound Used for the Treatment of Brain Tumors and Targeted Drug Delivery

A study completed by a Finnish researcher provides new insights into the limitations and potential new directions for the future advancement of transcranial ultrasound therapy. Active research is ongoing... Read more

Nuclear medicine

view channel

PET/CT Using FDG-Labeled Leukocytes Detects Infection in Acute Pancreatitis Patients

A study out of India that identifies infection in patients with pancreatic fluid collections may rapidly and effectively rule out active infection in the body. This treatment may help in making nuclear medicine imaging a mainstay in clinical management practices. Acute pancreatitis (AP) is an abrupt inflammation of the pancreas.... Read more

General/Advanced Imaging

view channel

Diagnostic Imaging Tests Ordered by General Practitioners in Australia Nearly Double in 10 Years

A 45% increase in diagnostic imaging tests ordered by Australian general practitioners (GPs) is being fueled by increasing GP visits, an escalating number of problems managed at doctor visits, and a higher probability that GPs order imaging tests for these problems, according to a new study. Based on a long-term national... Read more

Imaging IT

view channel
Image: An X-ray using the ClearRead bone suppression software technology (Photo courtesy of Riverain Technologies).

Bone Suppression Software Used to Optimize Diagnostic Capability of X-Ray Systems

Clinicians are gathering important information from the most routine imaging exam, the chest X-ray, by using advanced software that enhances X-ray images captured by the equipment they already have or... Read more

Industry News

view channel

Acquisition Includes Radiation Simulation Software for Radiotherapy Applications

Varian Medical Systems, Inc. (Palo Alto, CA, USA) has acquired certain assets of Transpire, Inc. (Gig Harbor, WA, USA) including the Acuros dose calculation software, which has been incorporated into Varian’s BrachyVision and Eclipse treatment planning software systems. The acquisition closed at the end of July 2014.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.